Further studies may be of benefit to determine if PRKG2/PDGFRB fusion is harbored by mast cells, which would suggest that the cases thus far described may represent a distinct clonal disorder, rather than a systemic mastocytosis with a second non-mast cell hematologic disorder [6]. Here, PRKG2 is linked to mastocytosis.